Session Details

U080 “Bread n’ Butter with a Side of Nutella”: Short n’ Sweet, High-Yield Updates on Management of Bread n’ Butter Dermatologic Diseases

Mon, Mar 22, 7:30 AM - 8:30 AM
1 CME Available Focus Session

DESCRIPTION

In this fast-paced, high-impact session, our expert team delivers “Short n’ Sweet” updates on the bread-and-butter dermatologic conditions you encounter every day. Each update is loaded with practical, evidence-based insights you can start using in clinic tomorrow — sure to impress colleagues, trainees, and patients alike. Whether you’re in training, private practice, or academic medicine, these clinical pearls will sharpen your decision-making and elevate your everyday care. No time to keep up with the latest derm evidence? Let us do the heavy lifting for you.

LEARNING OBJECTIVES

1.

Summarize real-world database and comparative effectiveness research on current treatments for common dermatologic diseases and specific disease phenotypes

2.

Summarize key updates on new, existing, and upcoming treatments for common dermatologic diseases — delivering practical insights that matter to trainees, community clinicians, and academic dermatologists alike.

3.

Diagnose and treat common dermatologic diseases using cutting-edge advances— with real-world applications for trainees, practicing dermatologists, and academic experts alike.

SCHEDULE

7:30 AM

Root Awakening: The Latest in Hair Loss

Kathie Pei Huang, MD, FAAD

7:40 AM

Field Goals: High Yield Updates in Actinic Keratosis and Keratinocyte Carcinoma Preventation

Lindsey Voller, MD, FAAD

7:50 AM

GLP1 in Dermatology: What’s New and What’s Next

Corey J. Georgesen, MD, FAAD

8:00 AM

Hidradenitis Suppurativa: What’s New and What’s Next

Vishnu Harikumar, MD, FAAD

8:10 AM

Pyoderma Gangrenosum: New Insights and Evolving Treatments

Brian Simmons, MD, FAAD

8:20 AM

Supportive Oncodermatology: What’s New and What’s Next

Jesse Philip Hirner, MD, FAAD

DIRECTOR

Erin Barrett, MD, MBA, FAAD

Erin Barrett, MD, MBA, FAAD

University of North Dakota School of Medicine and Health Science & Sanford-Fargo

SPEAKERS

Corey J. Georgesen, MD, FAAD

Corey J. Georgesen, MD, FAAD

Vishnu Harikumar, MD, FAAD

Vishnu Harikumar, MD, FAAD

Sanford Health

Jesse Philip Hirner, MD, FAAD

Jesse Philip Hirner, MD, FAAD

Kathie Pei Huang, MD, FAAD

Kathie Pei Huang, MD, FAAD

Brian Simmons, MD, FAAD

Brian Simmons, MD, FAAD

Dartmouth Gisel School of Medicine

Lindsey Voller, MD, FAAD

Lindsey Voller, MD, FAAD

DISCLOSURES

Erin Barrett, MD, MBA, FAAD

Eli Lilly – Investigator(No Compensation Received); Guidepoint Global, LLC – Other(Fees); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(No Compensation Received); Sanofi Speaker Programs – Speaker/Faculty Education(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); UCB Pharma – Advisory Board(Honoraria);

Corey J. Georgesen, MD, FAAD

No financial relationships exist with ineligible companies.

Vishnu Harikumar, MD, FAAD

No financial relationships exist with ineligible companies.

Jesse Philip Hirner, MD, FAAD

Abbvie – Speaker(Honoraria);

Kathie Pei Huang, MD, FAAD

AbbVie – Consultant (1099 relationship)(Fees); IQVIA Solutions Australia Pty Ltd – Other(Fees);

Brian Simmons, MD, FAAD

AbbVie – Investigator(No Compensation Received); Acelyrin – Investigator(No Compensation Received); Arcutis Biotherapeutics – Investigator(No Compensation Received); argenx – Investigator(Honoraria); Biofrontera – Investigator(No Compensation Received); Boehringer Ingelheim – Investigator(No Compensation Received); Eli Lilly – Investigator(No Compensation Received); Insmed Incorporated – Investigator(No Compensation Received); Pfizer Inc. – Advisory Board(Honoraria); Priovant Therapeutics – Investigator(No Compensation Received); Smart Practice – Investigator(No Compensation Received); Takeda Pharmaceuticals USA Inc – Investigator(No Compensation Received);

Lindsey Voller, MD, FAAD

No financial relationships exist with ineligible companies.